0
0
Almost everything anyone has ever told you about changing your body is a subtraction problem.
Eat less. Want less. Cut this out. Skip that. Hold out longer between meals. Every plan, every app, every piece of advice from a relative who means well — they all run on the same engine, which is doing without something you would rather have.
And it works, for a while. That is the cruel part. Subtraction works right up until the day your body decides it has had enough of being argued with, and then it takes back everything, usually with interest.
So a study published in late August is worth a look — not because it solves anything, and not because there is a pill you can go and ask for. There isn’t. But because of the direction it came at the problem from, which is almost the exact opposite of subtraction.
Burn Fat Without Losing Muscle: What the Study Actually Found
Researchers at UC Berkeley took a compound called TOFA — the full name is 5-tetradecyloxy-2-furoic acid, which is why everyone just says TOFA — and gave it to obese mice. Their findings were published in Science Advances on 21 August 2026.
The mice lost weight. On average, about 18% of their body weight. Their blood sugar control improved. Their fatty liver disease improved markedly.
Here is the part that makes it unusual: the mice did not eat less.
Their appetite was not suppressed. And they did not lose muscle along with the fat — which is the quiet tax that almost every weight-loss method collects, and the one that makes people weaker at the end of the process than they were at the start.
Instead, the compound raised how much energy the animals used. By as much as 18% — a separate measurement from the weight figure, and a coincidence of numbers rather than the same number twice.
Which raises an obvious question. If they weren’t eating less, and the weight came off anyway, where did the extra energy go?
The Detail That Makes This Strange
Normally, when a body burns noticeably more energy, there are two obvious explanations. Either it is moving more, or it is running hotter.
That is how stimulants work. It is how a fever works. Energy has to go somewhere, and it usually goes into motion or heat.
Neither happened here.
The mice did not become more physically active. Their body temperature did not rise. They were not fidgeting more, exercising more, or burning hot. They were simply doing something different with the fuel they already had on board.
What the compound appears to do is interfere with the production of lipids — cholesterol and triglycerides — while switching on genes that push cells to use fat as fuel and make more energy from it.
So nothing was taken away from the animal. Nothing extra was demanded of it. The instructions changed about what to do with what was already there.
That is a genuinely different shape of intervention, and if you have spent years in the subtraction cycle, it is worth sitting with for a second.
The Part Everyone Will Skip, and Shouldn’t
These were mice.
Not people. Mice.
Safety and dosing in humans have not been established. No clinical trials have begun. Nobody knows yet whether this does anything useful or safe in a human body, and the honest answer to “when can I get this” is that nobody can tell you, because the question has not been asked properly yet.
The researchers also found the effect was stronger when TOFA was combined with GLP-1 drugs — the family that includes the injectables people talk about constantly now. That is interesting. It is also still mice.
Plenty of things work beautifully in a mouse and do nothing in a person. This might be one of them. It is a real finding and a genuinely promising direction, and it is nowhere near being a treatment.
Nothing New Was Invented
Here is the detail that stayed with me longest, and it has nothing to do with weight.
TOFA is decades old.
It is not a new molecule. Nobody designed it in a lab last year. It has been sitting in the scientific literature for a long time, known, catalogued, and largely set aside — until somebody looked at it again and asked a different question of it.
The breakthrough, such as it is, wasn’t a discovery of something new. It was a re-reading of something already on the shelf.
That happens more often in science than the headlines suggest. The thing that turns out to matter was frequently there the whole time, filed under the wrong heading, waiting for someone to ask it a better question.
It happens in other places too. Researchers recently found that “forever chemicals” were not as permanent as the name promised — the permanence was an assumption, not a property. And a separate line of work on how depression stalls the making of new brain cells found something similar: the machinery for change was present, but the instructions had gone quiet.
There is an old idea, far older than any of this research, that runs along the same line.
Whenever people have written about a life genuinely changing — not being managed, not being white-knuckled, actually changing — almost none of those accounts describe it as subtraction. Nobody describes becoming a different person by successfully going without. The language is always about being remade. A new heart. New instructions for the same life. Something reordered rather than removed.
Which is a strange thing for ancient writers to have landed on, and a stranger thing for a metabolism paper to arrive at from the other direction.
What This Is Worth to You Today
Practically, in terms of your own body, this week: nothing. That is the honest answer. It is a mouse study and you cannot act on it.
But there is something here that is not about the compound.
If you have spent years assuming the only route available to you runs through going without — wanting less, needing less, taking up less room, being less hungry for whatever it is you are hungry for — it is worth knowing that this is an assumption, not a law. It is one mechanism. It is not the only one.
Some things change by being taken away. Other things change by being given different instructions. Those are not the same process, and confusing the two has exhausted a great many people who did nothing wrong except follow the only advice they were ever handed.
You are not a failed subtraction problem.
You might just have been given the wrong operation.
(If you are the sort of person who likes to understand how your own energy and eating patterns actually fit together — not as a plan to follow, just out of curiosity about the machinery — our free intermittent fasting finder walks through how different eating windows work. No sign-up, no plan to buy.)
Discussion Question
Most health advice is built on going without something. Do you think that is because subtraction genuinely works best — or because it is the easiest thing to sell and the easiest thing to measure? We would genuinely like to hear how you see it. Leave a comment below.
Share This
- “A compound made obese mice burn 18% more energy without eating less, moving more, or running a fever. They just did something different with the fuel they already had. Still only mice — but what a direction to come at it from.”
- “Every diet is a subtraction problem. This study wasn’t. Nothing was taken away from the animal and nothing extra was demanded of it — the instructions just changed about what to do with what was already there.”
- “The compound in that new metabolism study is decades old. Nobody invented anything. Somebody re-read something already sitting on the shelf and asked it a better question. That happens more than you’d think.”
Common Questions
What is TOFA?
TOFA is short for 5-tetradecyloxy-2-furoic acid, a compound that has existed in the scientific literature for decades. Research from UC Berkeley published in Science Advances on 21 August 2026 found that it interferes with the production of lipids such as cholesterol and triglycerides, while activating genes that push cells to use fat for fuel and produce more energy. It is an experimental compound, not an approved or available medication.
Did TOFA work in humans?
No. The 2026 UC Berkeley research was conducted in mice. Safety and dosing in humans have not been established, and no clinical trials have begun. Results that look strong in animal models frequently do not carry over to people, so no conclusions about human use can be drawn from this study.
How is TOFA different from GLP-1 drugs like Ozempic or Wegovy?
GLP-1 drugs work largely by reducing appetite, so a person eats less. In the 2026 mouse study, TOFA did not suppress appetite at all — the animals ate normally and still lost weight, because the compound increased the amount of energy their bodies used. The researchers also found the effect was stronger when TOFA was combined with GLP-1 drugs, though this too was observed only in mice.
What does it mean that the mice “burned more energy”?
The mice used as much as 18% more energy than they otherwise would have. What made this notable is that the extra energy did not come from increased physical activity or from a raised body temperature — the two usual explanations when a body burns more energy. The animals were not moving more or running hotter; their cells were processing the fuel already available differently.
Did the mice lose muscle along with fat?
No. The mice lost an average of about 18% of their body weight without significant muscle loss, and also showed improved blood sugar control and marked improvement in fatty liver disease. Muscle loss alongside fat loss is a common drawback of many weight-loss approaches, which is part of why this finding drew attention — though it remains an animal-model result only.
